CD52-directed Antibody Interactions [MoA] - N0000175079

Pharmacologic Class Information

Pharmacologic Code N0000175079
Pharmacologic Name CD52-directed Antibody Interactions
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD52-directed Antibody Interactions

The table contains 2 products whose active ingredient are classified under the same pharmacologic class CD52-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
58468-0200Lemtrada Non-Proprietary Name: AlemtuzumabInjection, Solution, ConcentrateIntravenousGenzyme CorporationACTIVE
58468-0357Campath Non-Proprietary Name: AlemtuzumabInjectionIntravenousGenzyme CorporationACTIVE